HEADER TRANSFERASE/INHIBITOR 10-SEP-08 3EFW
TITLE STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: AURORA KINASE A, AURORA-A, SERINE/THREONINE KINASE 15,
COMPND 5 AURORA/IPL1-RELATED KINASE 1, AURORA-RELATED KINASE 1, HARK1, BREAST
COMPND 6 TUMOR-AMPLIFIED KINASE;
COMPND 7 EC: 2.7.11.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS AURORAA, STK6_HUMAN, ATP-BINDING, CELL CYCLE, KINASE, NUCLEOTIDE-
KEYWDS 2 BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE,
KEYWDS 3 TRANSFERASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR S.F.BELLON,V.CEE,P.HUGHES,S.GEUNS-MEYER,D.WHITTINGTON
REVDAT 4 21-FEB-24 3EFW 1 REMARK
REVDAT 3 26-JUN-13 3EFW 1 JRNL
REVDAT 2 21-MAR-12 3EFW 1 DBREF REMARK SEQRES VERSN
REVDAT 2 2 1 KEYWDS HEADER
REVDAT 1 23-DEC-08 3EFW 0
JRNL AUTH V.J.CEE,A.C.CHENG,K.ROMERO,S.BELLON,C.MOHR,D.A.WHITTINGTON,
JRNL AUTH 2 A.BAK,J.BREADY,S.CAENEPEEL,A.COXON,H.L.DEAK,J.FRETLAND,Y.GU,
JRNL AUTH 3 B.L.HODOUS,X.HUANG,J.L.KIM,J.LIN,A.M.LONG,H.NGUYEN,
JRNL AUTH 4 P.R.OLIVIERI,V.F.PATEL,L.WANG,Y.ZHOU,P.HUGHES,S.GEUNS-MEYER
JRNL TITL PYRIDYL-PYRIMIDINE BENZIMIDAZOLE DERIVATIVES AS POTENT,
JRNL TITL 2 SELECTIVE, AND ORALLY BIOAVAILABLE INHIBITORS OF TIE-2
JRNL TITL 3 KINASE.
JRNL REF BIOORG.MED.CHEM.LETT. V. 19 424 2009
JRNL REFN ISSN 0960-894X
JRNL PMID 19062275
JRNL DOI 10.1016/J.BMCL.2008.11.056
REMARK 2
REMARK 2 RESOLUTION. 2.29 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.63
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 85.2
REMARK 3 NUMBER OF REFLECTIONS : 20740
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.260
REMARK 3 R VALUE (WORKING SET) : 0.258
REMARK 3 FREE R VALUE : 0.295
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1110
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35
REMARK 3 REFLECTION IN BIN (WORKING SET) : 793
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 44.70
REMARK 3 BIN R VALUE (WORKING SET) : 0.3100
REMARK 3 BIN FREE R VALUE SET COUNT : 33
REMARK 3 BIN FREE R VALUE : 0.5010
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3846
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 82
REMARK 3 SOLVENT ATOMS : 60
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.15
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.37000
REMARK 3 B22 (A**2) : -1.36000
REMARK 3 B33 (A**2) : 2.73000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.581
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.318
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.239
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.704
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4025 ; 0.007 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5465 ; 1.018 ; 1.994
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 476 ; 4.607 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;37.058 ;23.425
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 660 ;15.007 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;16.341 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.059 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3062 ; 0.003 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1657 ; 0.175 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2742 ; 0.298 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 153 ; 0.131 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.183 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.225 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2483 ; 0.432 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3856 ; 0.784 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1780 ; 0.854 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1609 ; 1.336 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3EFW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-08.
REMARK 100 THE DEPOSITION ID IS D_1000049272.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-MAY-04
REMARK 200 TEMPERATURE (KELVIN) : 130
REMARK 200 PH : 4.6
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : OSMIC
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22081
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8
REMARK 200 DATA REDUNDANCY : 3.600
REMARK 200 R MERGE (I) : 0.06200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41
REMARK 200 COMPLETENESS FOR SHELL (%) : 60.6
REMARK 200 DATA REDUNDANCY IN SHELL : 3.40
REMARK 200 R MERGE FOR SHELL (I) : 0.31600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.76
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE, 0.4 M AMMONIUM
REMARK 280 SULFATE, 15% PEG 4000, PH 4.6, VAPOR DIFFUSION, TEMPERATURE 273K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.87600
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.87600
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.25550
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.72400
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.25550
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.72400
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.87600
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.25550
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.72400
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.87600
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.25550
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.72400
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LYS A 125
REMARK 465 GLY A 276
REMARK 465 TRP A 277
REMARK 465 SER A 278
REMARK 465 VAL A 279
REMARK 465 HIS A 280
REMARK 465 ALA A 281
REMARK 465 PRO A 282
REMARK 465 SER A 283
REMARK 465 SER A 284
REMARK 465 ARG A 285
REMARK 465 ARG A 286
REMARK 465 THR A 287
REMARK 465 THR A 288
REMARK 465 LEU A 289
REMARK 465 CYS A 290
REMARK 465 GLY A 291
REMARK 465 THR A 292
REMARK 465 GLY A 303
REMARK 465 ARG A 304
REMARK 465 MET A 305
REMARK 465 HIS A 306
REMARK 465 ASP A 307
REMARK 465 GLU A 308
REMARK 465 LYS A 389
REMARK 465 PRO A 390
REMARK 465 SER A 391
REMARK 465 LYS B 125
REMARK 465 GLY B 276
REMARK 465 TRP B 277
REMARK 465 SER B 278
REMARK 465 VAL B 279
REMARK 465 HIS B 280
REMARK 465 ALA B 281
REMARK 465 PRO B 282
REMARK 465 SER B 283
REMARK 465 SER B 284
REMARK 465 ARG B 285
REMARK 465 ARG B 286
REMARK 465 THR B 287
REMARK 465 THR B 288
REMARK 465 LEU B 289
REMARK 465 CYS B 290
REMARK 465 GLY B 291
REMARK 465 THR B 292
REMARK 465 GLY B 303
REMARK 465 ARG B 304
REMARK 465 MET B 305
REMARK 465 HIS B 306
REMARK 465 ASP B 307
REMARK 465 PRO B 390
REMARK 465 SER B 391
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 143 CG CD CE NZ
REMARK 470 ARG A 151 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 156 CG CD CE NZ
REMARK 470 GLN A 177 CG CD OE1 NE2
REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 181 CG CD OE1 OE2
REMARK 470 HIS A 248 CG ND1 CD2 CE1 NE2
REMARK 470 LYS A 250 CG CD CE NZ
REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 255 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 258 CG CD CE NZ
REMARK 470 ASN A 332 CG OD1 ND2
REMARK 470 TYR A 334 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 GLN A 335 CG CD OE1 NE2
REMARK 470 GLN B 127 CG CD OE1 NE2
REMARK 470 LYS B 143 CG CD CE NZ
REMARK 470 LYS B 166 CG CD CE NZ
REMARK 470 GLU B 170 CG CD OE1 OE2
REMARK 470 LYS B 171 CG CD CE NZ
REMARK 470 ARG B 179 CG CD NE CZ NH1 NH2
REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2
REMARK 470 ARG B 251 CG CD NE CZ NH1 NH2
REMARK 470 ARG B 255 CG CD NE CZ NH1 NH2
REMARK 470 TYR B 334 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 GLN B 335 CG CD OE1 NE2
REMARK 470 LYS B 389 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 407 O HOH A 444 3655 2.11
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 155 -5.34 -140.57
REMARK 500 ASP A 202 -137.33 -118.03
REMARK 500 SER A 226 -54.10 72.82
REMARK 500 ARG A 255 -133.77 -74.44
REMARK 500 ASP A 294 -16.90 -49.97
REMARK 500 LYS B 143 99.46 -65.94
REMARK 500 LEU B 159 -157.79 -143.58
REMARK 500 ASP B 202 -141.71 -122.29
REMARK 500 SER B 226 -45.55 76.36
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AK8 A 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AK8 B 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 405
DBREF 3EFW A 125 391 UNP O14965 STK6_HUMAN 125 391
DBREF 3EFW B 125 391 UNP O14965 STK6_HUMAN 125 391
SEQRES 1 A 267 LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG
SEQRES 2 A 267 PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA
SEQRES 3 A 267 ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS VAL
SEQRES 4 A 267 LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS
SEQRES 5 A 267 GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG
SEQRES 6 A 267 HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP
SEQRES 7 A 267 ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU
SEQRES 8 A 267 GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE
SEQRES 9 A 267 ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA
SEQRES 10 A 267 ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS
SEQRES 11 A 267 ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA
SEQRES 12 A 267 GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS
SEQRES 13 A 267 ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR LEU
SEQRES 14 A 267 ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS
SEQRES 15 A 267 ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS
SEQRES 16 A 267 TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN
SEQRES 17 A 267 THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU
SEQRES 18 A 267 PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP
SEQRES 19 A 267 LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG
SEQRES 20 A 267 PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR
SEQRES 21 A 267 ALA ASN SER SER LYS PRO SER
SEQRES 1 B 267 LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG
SEQRES 2 B 267 PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA
SEQRES 3 B 267 ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS VAL
SEQRES 4 B 267 LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS
SEQRES 5 B 267 GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG
SEQRES 6 B 267 HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP
SEQRES 7 B 267 ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU
SEQRES 8 B 267 GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE
SEQRES 9 B 267 ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA
SEQRES 10 B 267 ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS
SEQRES 11 B 267 ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA
SEQRES 12 B 267 GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS
SEQRES 13 B 267 ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR LEU
SEQRES 14 B 267 ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS
SEQRES 15 B 267 ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS
SEQRES 16 B 267 TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN
SEQRES 17 B 267 THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU
SEQRES 18 B 267 PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP
SEQRES 19 B 267 LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG
SEQRES 20 B 267 PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR
SEQRES 21 B 267 ALA ASN SER SER LYS PRO SER
HET AK8 A 404 36
HET SO4 A 405 5
HET AK8 B 404 36
HET SO4 B 405 5
HETNAM AK8 1-[3-METHYL-4-({3-[2-(METHYLAMINO)PYRIMIDIN-4-
HETNAM 2 AK8 YL]PYRIDIN-2-YL}OXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)
HETNAM 3 AK8 PHENYL]UREA
HETNAM SO4 SULFATE ION
FORMUL 3 AK8 2(C25 H21 F3 N6 O2)
FORMUL 4 SO4 2(O4 S 2-)
FORMUL 7 HOH *60(H2 O)
HELIX 1 1 ALA A 129 GLU A 131 5 3
HELIX 2 2 LYS A 166 GLY A 173 1 8
HELIX 3 3 VAL A 174 HIS A 187 1 14
HELIX 4 4 THR A 217 SER A 226 1 10
HELIX 5 5 ASP A 229 SER A 249 1 21
HELIX 6 6 LYS A 258 GLU A 260 5 3
HELIX 7 7 PRO A 297 ILE A 301 5 5
HELIX 8 8 LYS A 309 GLY A 325 1 17
HELIX 9 9 THR A 333 VAL A 344 1 12
HELIX 10 10 THR A 353 LEU A 364 1 12
HELIX 11 11 ASN A 367 ARG A 371 5 5
HELIX 12 12 MET A 373 GLU A 379 1 7
HELIX 13 13 HIS A 380 SER A 387 1 8
HELIX 14 14 ALA B 129 GLU B 131 5 3
HELIX 15 15 LYS B 166 GLY B 173 1 8
HELIX 16 16 VAL B 174 SER B 186 1 13
HELIX 17 17 THR B 217 SER B 226 1 10
HELIX 18 18 ASP B 229 SER B 249 1 21
HELIX 19 19 LYS B 258 GLU B 260 5 3
HELIX 20 20 PRO B 297 GLU B 302 1 6
HELIX 21 21 LYS B 309 GLY B 325 1 17
HELIX 22 22 THR B 333 ARG B 343 1 11
HELIX 23 23 THR B 353 LEU B 364 1 12
HELIX 24 24 ASN B 367 ARG B 371 5 5
HELIX 25 25 LEU B 374 GLU B 379 1 6
HELIX 26 26 HIS B 380 SER B 387 1 8
SHEET 1 A 5 PHE A 133 GLY A 142 0
SHEET 2 A 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139
SHEET 3 A 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150
SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164
SHEET 5 A 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207
SHEET 1 B 2 LEU A 262 LEU A 264 0
SHEET 2 B 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263
SHEET 1 C 5 PHE B 133 GLY B 142 0
SHEET 2 C 5 GLY B 145 GLU B 152 -1 O VAL B 147 N LEU B 139
SHEET 3 C 5 ILE B 158 PHE B 165 -1 O LEU B 161 N TYR B 148
SHEET 4 C 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164
SHEET 5 C 5 LEU B 196 HIS B 201 -1 N PHE B 200 O TYR B 207
SHEET 1 D 2 LEU B 262 LEU B 264 0
SHEET 2 D 2 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263
SITE 1 AC1 15 LYS A 143 PHE A 144 VAL A 147 LYS A 162
SITE 2 AC1 15 VAL A 174 GLN A 177 LEU A 178 LEU A 210
SITE 3 AC1 15 GLU A 211 TYR A 212 ALA A 213 LEU A 263
SITE 4 AC1 15 ALA A 273 SO4 A 405 HOH A 416
SITE 1 AC2 4 ASN A 261 ASP A 274 PHE A 275 AK8 A 404
SITE 1 AC3 16 LYS B 143 VAL B 147 LYS B 162 VAL B 174
SITE 2 AC3 16 GLN B 177 LEU B 178 GLU B 181 LEU B 210
SITE 3 AC3 16 GLU B 211 ALA B 213 ASN B 261 LEU B 263
SITE 4 AC3 16 ALA B 273 PHE B 275 SO4 B 405 HOH B 414
SITE 1 AC4 3 ASP B 274 PHE B 275 AK8 B 404
CRYST1 118.511 125.448 75.752 90.00 90.00 90.00 C 2 2 21 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008438 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007971 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013201 0.00000